11:20 AM EDT, 09/18/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher Thursday morning, rising 0.71% to 1,554.06 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications ( SQNS ) and pharmaceutical company Novo Nordisk ( NVO ) , which climbed 8.3% and 6.6%, respectively. They were followed by 3D printer company Materialise (MTLS) and biopharmaceutical company Cellectis ( CLLS ) , which advanced 4.5% and 4.1%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and telecommunications operator Telefonica ( TEF ) , which fell 1.4% and 1.2%, respectively. They were followed by financial services company ING Group (ING) and petroleum refiner Equinor ( EQNR ) , which were off 0.6% and 0.4%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and Akari Therapeutics ( AKTX ) , which rose 14% and 9%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company NuCana ( NCNA ) , which were up 5.9% and 3.7%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company AstraZeneca ( AZN ) and tobacco company British American Tobacco ( BTI ) , which dropped 1.9% and 1.8%, respectively. They were followed by telecommunications operator Vodafone Group ( VOD ) and mining company BHP Group ( BHP ) , which were down 1.7% and 1.4%, respectively.